Grant: CIHR Fellowship
University of Toronto
$110,000.00
The Ileal Crohn's Disease Microbiome Initiative: Using metagenomics to define the structure and function of the intestinal microbiome, including the influence of human genetic variants, in ileal Crohn's disease
EF 2013-14
Résumé
Inflammatory bowel disease (IBD) is a chronic inflammatory condition that affects Canadians more frequently than any other population in the world. Its major forms include Crohn's disease and ulcerative colitis. Crohn's disease may affect anywhere in the bowel, most commonly the end of the small bowel known as the ileum. Patients with ileal Crohn's disease have symptoms including abdominal pain and diarrhea, and can develop serious complications such as bowel perforation. Patients require medication, hospitalization, and surgery.
Genetic studies have associated variations in genes involved in immune response to gut microbes with ileal Crohn's disease. In fact, we are increasingly aware of the importance of gut microbes, known in their totality as the 'microbiome', on diverse illnesses such as IBD, obesity, and even psychiatric illness. These discoveries are made possible by new genetic sequencing technologies that allow cataloguing of the bacterial species that inhabit us.
We propose to use these technologies to investigate the composition of the gut microbiome in ileal Crohn's disease, compared to other IBD patients and healthy individuals. Using novel computational techniques, we can predict the metabolic function of these microbes, to give insight into their role in disease. We will also explore how human genetic variants associated with Crohn's disease affect the composition and function of gut microbes.
We will explore this by sequencing the bacteria found in biopsies taken from the ileum of Crohn's disease patients with active and inactive disease, during routine colonoscopy. We will take blood samples to determine genetic variants in these patients. Understanding the microbial and human genetic changes that underlie IBD will lead to development of new diagnostic tools and medications to improve care of patients with this debilitating disease. It will lead to foundational understanding of the mechanisms that underlie development of this common disease.
Programme
CIHR Fellowship
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
300454
Name
Murdoch Travis B
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Partnername
Canadian Association of Gastroenterology (Oakville, Ontario)
Instname2
Nutrition, Metabolism and Diabetes
Theme2
Biomedical
Prcname2
Health Professional Awards - Fellowships
Projecttitle
The Ileal Crohn's Disease Microbiome Initiative: Using metagenomics to define the structure and function of the intestinal microbiome, including the influence of human genetic variants, in ileal Crohn's disease
Programtype2
Fellowship Programs
Orgnameinp2
University of Toronto
Cihramount2
$110,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Bioinformatics; Crohn'S Disease; Genetics; Ileitis; Inflammatory Bowel Disease; Metagenomics; Microbiome
Abstract
Inflammatory bowel disease (IBD) is a chronic inflammatory condition that affects Canadians more frequently than any other population in the world. Its major forms include Crohn's disease and ulcerative colitis. Crohn's disease may affect anywhere in the bowel, most commonly the end of the small bowel known as the ileum. Patients with ileal Crohn's disease have symptoms including abdominal pain and diarrhea, and can develop serious complications such as bowel perforation. Patients require medication, hospitalization, and surgery.
Genetic studies have associated variations in genes involved in immune response to gut microbes with ileal Crohn's disease. In fact, we are increasingly aware of the importance of gut microbes, known in their totality as the 'microbiome', on diverse illnesses such as IBD, obesity, and even psychiatric illness. These discoveries are made possible by new genetic sequencing technologies that allow cataloguing of the bacterial species that inhabit us.
We propose to use these technologies to investigate the composition of the gut microbiome in ileal Crohn's disease, compared to other IBD patients and healthy individuals. Using novel computational techniques, we can predict the metabolic function of these microbes, to give insight into their role in disease. We will also explore how human genetic variants associated with Crohn's disease affect the composition and function of gut microbes.
We will explore this by sequencing the bacteria found in biopsies taken from the ileum of Crohn's disease patients with active and inactive disease, during routine colonoscopy. We will take blood samples to determine genetic variants in these patients. Understanding the microbial and human genetic changes that underlie IBD will lead to development of new diagnostic tools and medications to improve care of patients with this debilitating disease. It will lead to foundational understanding of the mechanisms that underlie development of this common disease.
Competitiondate
201311
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Murdoch, Travis B
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $110,000~ $0~